Holen Sie sich die Stockscreener-App
52.09
0.29%
0.15
Schlusskurs vom Vortag:
$51.94
Offen:
$51.46
24-Stunden-Volumen:
1.47M
Relative Volume:
0.57
Marktkapitalisierung:
$7.13B
Einnahmen:
$550.17M
Nettoeinkommen (Verlust:
$201.35M
KGV:
52.09
EPS:
1
Netto-Cashflow:
$232.07M
1W Leistung:
+2.10%
1M Leistung:
-9.80%
6M Leistung:
-1.72%
1J Leistung:
+87.71%
1-Tages-Spanne:
$51.15
$52.26
1-Wochen-Bereich:
$51.15
$52.80
52-Wochen-Spanne:
$25.00
$85.21
Doximity Inc Stock (DOCS) Company Profile
Firmenname
Doximity Inc
Sektor
Branche
Telefon
(650) 549-4330
Adresse
500 THIRD STREET, SAN FRANCISCO
Vergleichen Sie DOCS mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
DOCS
Doximity Inc
|
52.09 | 9.58B | 550.17M | 201.35M | 232.07M | 1.00 |
|
VEEV
Veeva Systems Inc
|
279.70 | 37.97B | 2.75B | 714.14M | 1.09B | 4.33 |
|
TEM
Tempus Ai Inc
|
55.18 | 10.83B | 803.32M | -709.10M | -212.68M | -7.8003 |
|
HQY
Healthequity Inc
|
100.61 | 8.58B | 1.15B | 96.70M | -161.99M | 1.09 |
|
WAY
Waystar Holding Corp
|
39.98 | 6.68B | 906.14M | -52.62M | 89.62M | -0.3621 |
Doximity Inc Stock (DOCS) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-02-07 | Hochstufung | Leerink Partners | Market Perform → Outperform |
| 2025-02-07 | Hochstufung | Piper Sandler | Neutral → Overweight |
| 2024-12-20 | Eingeleitet | Stephens | Equal-Weight |
| 2024-12-04 | Eingeleitet | Mizuho | Neutral |
| 2024-11-15 | Eingeleitet | Goldman | Neutral |
| 2024-11-14 | Hochstufung | Morgan Stanley | Underweight → Equal-Weight |
| 2024-11-13 | Herabstufung | Canaccord Genuity | Buy → Hold |
| 2024-11-08 | Hochstufung | KeyBanc Capital Markets | Sector Weight → Overweight |
| 2024-11-08 | Hochstufung | Wells Fargo | Underweight → Equal Weight |
| 2024-10-15 | Hochstufung | Barclays | Equal Weight → Overweight |
| 2024-08-09 | Hochstufung | Needham | Hold → Buy |
| 2024-07-18 | Herabstufung | Wells Fargo | Equal Weight → Underweight |
| 2024-04-25 | Hochstufung | JP Morgan | Underweight → Neutral |
| 2024-02-26 | Eingeleitet | Leerink Partners | Market Perform |
| 2024-01-03 | Eingeleitet | Barclays | Equal Weight |
| 2024-01-02 | Hochstufung | BofA Securities | Underperform → Neutral |
| 2023-08-09 | Herabstufung | Guggenheim | Buy → Neutral |
| 2023-08-09 | Herabstufung | Needham | Buy → Hold |
| 2023-08-03 | Herabstufung | Piper Sandler | Overweight → Neutral |
| 2023-05-01 | Herabstufung | Wells Fargo | Overweight → Equal Weight |
| 2023-01-06 | Herabstufung | Morgan Stanley | Equal-Weight → Underweight |
| 2022-10-31 | Eingeleitet | Wells Fargo | Overweight |
| 2022-10-24 | Eingeleitet | Evercore ISI | In-line |
| 2022-10-13 | Eingeleitet | BTIG Research | Neutral |
| 2022-09-16 | Eingeleitet | KeyBanc Capital Markets | Sector Weight |
| 2022-09-07 | Eingeleitet | Truist | Hold |
| 2022-08-05 | Herabstufung | BofA Securities | Neutral → Underperform |
| 2022-07-28 | Eingeleitet | Berenberg | Buy |
| 2022-05-18 | Bestätigt | BofA Securities | Neutral |
| 2022-05-18 | Bestätigt | Goldman | Buy |
| 2022-05-18 | Bestätigt | Guggenheim | Buy |
| 2022-05-18 | Bestätigt | Jefferies | Buy |
| 2022-05-18 | Bestätigt | Morgan Stanley | Equal-Weight |
| 2022-05-18 | Bestätigt | Needham | Buy |
| 2022-04-07 | Eingeleitet | Guggenheim | Buy |
| 2022-04-04 | Eingeleitet | BofA Securities | Neutral |
| 2022-02-11 | Eingeleitet | Goldman | Buy |
| 2021-12-14 | Herabstufung | JP Morgan | Neutral → Underweight |
| 2021-12-02 | Eingeleitet | Jefferies | Buy |
| 2021-11-17 | Eingeleitet | Robert W. Baird | Outperform |
| 2021-11-10 | Bestätigt | Canaccord Genuity | Buy |
| 2021-11-10 | Bestätigt | Goldman | Neutral |
| 2021-11-10 | Bestätigt | Morgan Stanley | Equal-Weight |
| 2021-11-10 | Bestätigt | Needham | Buy |
| 2021-11-10 | Bestätigt | Piper Sandler | Overweight |
| 2021-08-26 | Herabstufung | JP Morgan | Overweight → Neutral |
| 2021-07-19 | Eingeleitet | Canaccord Genuity | Buy |
| 2021-07-19 | Eingeleitet | Goldman | Neutral |
| 2021-07-19 | Eingeleitet | JP Morgan | Overweight |
| 2021-07-19 | Eingeleitet | Morgan Stanley | Equal-Weight |
| 2021-07-19 | Eingeleitet | Piper Sandler | Overweight |
| 2021-07-19 | Eingeleitet | Raymond James | Outperform |
| 2021-07-19 | Eingeleitet | SVB Leerink | Outperform |
| 2021-07-19 | Eingeleitet | William Blair | Outperform |
Alle ansehen
Doximity Inc Aktie (DOCS) Neueste Nachrichten
Doximity (NASDAQ:DOCS) Price Target Lowered to $60.00 at JPMorgan Chase & Co. - MarketBeat
Voloridge Investment Management LLC Sells 154,196 Shares of Doximity, Inc. (NASDAQ:DOCS) - MarketBeat
Doximity, Inc. (NASDAQ:DOCS) Shares Sold by UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC - MarketBeat
Doximity, Inc. (NASDAQ:DOCS) Receives $61.22 Average Target Price from Brokerages - MarketBeat
Doximity (DOCS) Poised to Benefit from Evolving Healthcare Engagement Trends | DOCS Stock News - GuruFocus
Wealthedge Investment Advisors LLC Invests $826,000 in Doximity, Inc. (NASDAQ:DOCS) - MarketBeat
Mackenzie Financial Corp Invests $7.14 Million in Doximity, Inc. (NASDAQ:DOCS) - MarketBeat
Upcoming Opportunities in Patient Communication Solutions - openPR.com
Nuveen Asset Management LLC Grows Holdings in Doximity, Inc. (NASDAQ:DOCS) - MarketBeat
Doximity, Inc. (NASDAQ:DOCS) Position Reduced by MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. - MarketBeat
Doximity (DOCS) Price Target Lowered by JP Morgan | DOCS Stock News - GuruFocus
Doximity (DOCS) Price Target Lowered by JPMorgan | DOCS Stock Ne - GuruFocus
Doximity (DOCS) Price Target Lowered by JPMorgan | DOCS Stock News - GuruFocus
The Strong Earnings Posted By Doximity (NYSE:DOCS) Are A Good Indication Of The Strength Of The Business - Yahoo Finance
Doximity (NASDAQ:DOCS) PT Set at $50.00 by The Goldman Sachs Group - MarketBeat
Cache Advisors LLC Takes $753,000 Position in Doximity, Inc. (NASDAQ:DOCS) - MarketBeat
Nomura Holdings Inc. Takes Position in Doximity, Inc. (NASDAQ:DOCS) - MarketBeat
Man Group plc Decreases Stake in Doximity, Inc. (NASDAQ:DOCS) - MarketBeat
Doximity’s SWOT analysis: digital health leader faces growth challenges - Investing.com
Strategic Global Advisors LLC Takes $1.51 Million Position in Doximity, Inc. (NASDAQ:DOCS) - MarketBeat
Teza Capital Management LLC Purchases Shares of 38,090 Doximity, Inc. (NASDAQ:DOCS) - MarketBeat
Jim Cramer on Doximity (DOCS): “I Cannot Get Behind That” - MSN
Jim Cramer Discussed These 9 Stocks Recently - Insider Monkey
Global Telemedicine Market to grow at a CAGR of 14.69% by 2030, - openPR.com
Jim Cramer Praises Rivian, Recommends Pan American SilverLucid Group (NASDAQ:LCID), Doximity (NYSE:DOCS) - Benzinga
Gotham Asset Management LLC Has $2.56 Million Stake in Doximity, Inc. (NASDAQ:DOCS) - MarketBeat
Lazard Asset Management LLC Reduces Stock Position in Doximity, Inc. (NASDAQ:DOCS) - MarketBeat
Point72 Hong Kong Ltd Has $704,000 Holdings in Doximity, Inc. (NASDAQ:DOCS) - MarketBeat
Doximity, Inc. Long-Term Shareholder Announcement: Johnson - GlobeNewswire
Doximity (DOCS) Sees Increased Call Option Activity | DOCS Stock News - GuruFocus
Doximity to Present at the William Blair 45th Annual Growth Stock Conference - Bluefield Daily Telegraph
Doximity (DOCS): Goldman Sachs Lowers Price Target Amidst Neutral Rating | DOCS Stock News - GuruFocus
Doximity (DOCS): Goldman Sachs Lowers Price Target Amidst Neutra - GuruFocus
Goldman cuts Doximity stock price target to $50, maintains neutral By Investing.com - Investing.com Nigeria
Telemedicine for Healthcare Providers: Market Insights & - openPR.com
Goldman cuts Doximity stock price target to $50, maintains neutral - Investing.com Australia
Doximity (NASDAQ:DOCS) Stock Price Down 3.8% Following Analyst Downgrade - Defense World
Doximity, Inc. (NYSE:DOCS) Q4 2025 Earnings Call Transcript - MSN
Decoding Doximity Inc (DOCS): A Strategic SWOT Insight - GuruFocus
Doximity, Inc. (NASDAQ:DOCS) Shares Purchased by Polar Capital Holdings Plc - MarketBeat
Doximity: A Closer Look At Its Investment Potential - Barchart.com
Finanzdaten der Doximity Inc-Aktie (DOCS)
Umsatz
Nettogewinn
Free Cashflow
ENV
3.68%
0.37%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):